Clinical Trial Update: High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating high-dose methotrexate for adult acute lymphoblastic leukemia. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Methotrexate (high-dose) (Methotrexate)

Snippet

Sponsor: Japan Adult Leukemia Study Group | Conditions: Lymphoblastic Leukemia, Acute | Phase 3 | Status: UNKNOWN